Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021

SELL
$0.93 - $1.18 $33,480 - $42,480
-36,000 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$1.62 - $3.05 $140,940 - $265,350
-87,000 Reduced 70.73%
36,000 $74,000
Q4 2020

Feb 01, 2021

SELL
$1.44 - $1.98 $43,200 - $59,400
-30,000 Reduced 19.61%
123,000 $192,000
Q3 2020

Nov 02, 2020

BUY
$0.8 - $2.33 $122,400 - $356,490
153,000 New
153,000 $265,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.